 NEW YORK, Feb. 25, 2021 PRNewswire -- WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Pandion Therapeutics, Inc. Pandion or the Company NASDAQ: PAND in connection with the proposed all-cash acquisition of... 